Cargando…
MO30-1 Factors critical for the acquisition of antibody after SARS-CoV-2 vaccination in malignant lymphoma patients
Autores principales: | Okamoto, Akinao, Hidetsugu, Fujigaki, Chisako, Iriyama, Naoe, Goto, Hideyuki, Yamamoto, Keichiro, Mihara, Yoko, Inaguma, Yasuo, Miura, Katsuya, Furukawa, Yukiya, Yamamoto, Yoshiki, Akatsuka, Senji, Kasahara, Kotaro, Miyao, Okamoto, Masataka, Saito, Kuniaki, Tomita, Akihiho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300380/ http://dx.doi.org/10.1016/j.annonc.2022.05.179 |
Ejemplares similares
-
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
por: Okamoto, Akinao, et al.
Publicado: (2022) -
Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases
por: Iriyama, Chisako, et al.
Publicado: (2023) -
Prognostic significance of Epstein–Barr virus DNA detection in pretreatment serum in diffuse large B‐cell lymphoma
por: Okamoto, Akinao, et al.
Publicado: (2015) -
Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses
por: Iriyama, Chisako, et al.
Publicado: (2021) -
Antibody testing for COVID-19 in patients with acute coronary syndrome in Aichi Prefecture
por: Yoshinaga, Masataka, et al.
Publicado: (2022)